Medical Properties Trust, Inc. (NYSE:MPW) Expected to Announce Earnings of $0.39 Per Share

Brokerages expect that Medical Properties Trust, Inc. (NYSE:MPW) will report earnings per share (EPS) of $0.39 for the current fiscal quarter, Zacks Investment Research reports. Five analysts have made estimates for Medical Properties Trust’s earnings, with the lowest EPS estimate coming in at $0.38 and the highest estimate coming in at $0.40. Medical Properties Trust reported earnings per share of $0.33 in the same quarter last year, which would suggest a positive year-over-year growth rate of 18.2%. The business is expected to report its next quarterly earnings results on Thursday, October 29th.

According to Zacks, analysts expect that Medical Properties Trust will report full year earnings of $1.53 per share for the current fiscal year, with EPS estimates ranging from $1.50 to $1.55. For the next year, analysts anticipate that the business will post earnings of $1.63 per share, with EPS estimates ranging from $1.62 to $1.66. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, July 30th. The real estate investment trust reported $0.38 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.38. Medical Properties Trust had a net margin of 38.41% and a return on equity of 6.29%. The business had revenue of $291.84 million during the quarter, compared to analysts’ expectations of $310.89 million. During the same quarter in the previous year, the company earned $0.31 EPS. The business’s quarterly revenue was up 51.6% compared to the same quarter last year.

Several research analysts recently issued reports on MPW shares. Zacks Investment Research upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a research note on Saturday, September 12th. Deutsche Bank downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating and dropped their price target for the company from $23.00 to $19.00 in a report on Friday, July 10th. Colliers Secur. started coverage on shares of Medical Properties Trust in a report on Wednesday, September 9th. They issued a “buy” rating and a $23.00 price objective on the stock. SunTrust Banks raised their price objective on shares of Medical Properties Trust from $19.00 to $20.00 and gave the stock a “buy” rating in a report on Thursday, June 25th. Finally, Mizuho raised shares of Medical Properties Trust from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $20.00 to $23.00 in a report on Monday, August 24th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $21.12.

In related news, Director Michael G. Stewart sold 5,000 shares of the company’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $19.09, for a total value of $95,450.00. Following the completion of the sale, the director now directly owns 220,056 shares of the company’s stock, valued at $4,200,869.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO R Steven Hamner sold 220,000 shares of the company’s stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $19.12, for a total transaction of $4,206,400.00. Following the completion of the sale, the chief financial officer now directly owns 1,605,829 shares of the company’s stock, valued at $30,703,450.48. The disclosure for this sale can be found here. Insiders have sold 599,069 shares of company stock valued at $11,362,383 over the last three months. Insiders own 1.15% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Credit Agricole S A purchased a new stake in Medical Properties Trust in the first quarter worth about $25,000. BDO Wealth Advisors LLC purchased a new stake in Medical Properties Trust in the first quarter worth about $26,000. tru Independence LLC lifted its stake in Medical Properties Trust by 69.0% in the second quarter. tru Independence LLC now owns 2,450 shares of the real estate investment trust’s stock worth $46,000 after acquiring an additional 1,000 shares during the period. FinTrust Capital Advisors LLC lifted its stake in Medical Properties Trust by 93.8% in the second quarter. FinTrust Capital Advisors LLC now owns 2,892 shares of the real estate investment trust’s stock worth $54,000 after acquiring an additional 1,400 shares during the period. Finally, Acadian Asset Management LLC purchased a new stake in Medical Properties Trust in the first quarter worth about $64,000. 83.19% of the stock is owned by institutional investors.

NYSE MPW remained flat at $$17.60 during trading on Tuesday. 304,047 shares of the company’s stock traded hands, compared to its average volume of 4,370,985. The company has a current ratio of 3.69, a quick ratio of 3.69 and a debt-to-equity ratio of 1.10. Medical Properties Trust has a 1-year low of $12.35 and a 1-year high of $24.29. The firm has a market capitalization of $9.31 billion, a P/E ratio of 21.41, a price-to-earnings-growth ratio of 1.56 and a beta of 0.50. The stock has a 50 day simple moving average of $18.34 and a two-hundred day simple moving average of $17.97.

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 8th. Stockholders of record on Thursday, September 10th will be paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 6.14%. The ex-dividend date is Wednesday, September 9th. Medical Properties Trust’s dividend payout ratio is currently 83.08%.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Recommended Story: Key terms to understand channel trading

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.